mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/P13K/Akt pathway

• 收藏
• 分享

专利权人:

LLC;Signal Pharmaceuticals

发明人:

Elsner, Jan,Harris, Roy L.,Lee, Branden,Mortensen, Deborah,Packard, Garrick,Papa, Patrick,Perrin-Ninkovic, Sophie,Riggs, Jennifer,Sankar, Sabita,Sapienza, John,Shevlin, Graziella,Tehrani, Lida,Xu, Wei

申请号：

AU2009320137

公开号：

AU2009320137B2

申请日:

2009.10.27

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

Provided herein are Heteroaryl Compounds having the following structure: R2 N (I) or (II) wherein R1 -R4 are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, neurodegenerative diseases, diabetes, obesity, neurological disorders, age-related diseases, or cardiovascular conditions, comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/